Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
University Of Maryland Pediatric Associates, PA
22 S Green St, 
Baltimore, MD 

Overview

Teresa York is a Pediatric Hematologist Oncology provider in Baltimore, Maryland. Dr. York is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hereditary Spherocytosis, Hemoglobin SC Disease, and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 10 peer reviewed articles and participating in 25 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in MD
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

UNIVERSITY OF MARYLAND PEDIATRIC ASSOCIATES, PA
22 S Green St, Baltimore, MD 21201

Additional Areas of Focus

Dr. York has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


25 Clinical Trials

Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
A Phase 3 Trial Investigating Blinatumomab (NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
Treatment of Patients With Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-Lineage Lymphoblastic Lymphoma (B-LLy)
Renal Tumors Classification, Biology, and Banking Study
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
View 24 Less Clinical Trials

10 Total Publications

Muscle Properties, Gross Motor Performance, and Quality of Life in Children With Sickle Cell Disease.
Similar Doctors
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
111 Michigan Ave Nw, 5th Floor Main, Suite 5207, 
Washington, DC 
 (32.6 miles away)
Languages Spoken:
English

Catherine Bollard is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Bollard is rated as a Distinguished provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Hodgkin Lymphoma, Graft Versus Host Disease (GvHD), Leukemia, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Transplant.

Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
111 Michigan Ave Nw, 
Washington, DC 
 (32.6 miles away)
Languages Spoken:
English

Holly Deluca is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Deluca is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). Her top areas of expertise are Sickle Cell Disease, Acute Lymphoblastic Leukemia (ALL), Hereditary Spherocytosis, and Hemoglobin SC Disease.

Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
Experienced in Primary Mediastinal B-Cell Lymphoma (PMBCL)
Pediatric Hematology Oncology
111 Michigan Ave NW, 
Washington, DC 
 (32.6 miles away)
Languages Spoken:
English

Gabriel Robbins is a Pediatric Hematologist Oncology provider in Washington, Washington, D.c.. Dr. Robbins is rated as an Experienced provider by MediFind in the treatment of Primary Mediastinal B-Cell Lymphoma (PMBCL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Fanconi Anemia, Leukemia, Primary Mediastinal B-Cell Lymphoma (PMBCL), and Bone Marrow Aspiration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. York's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile